P/E (MRFY) | Fwd. P/E (12 Mo.) | PEG | 1 Yr. EPS Growth Rate | |
---|---|---|---|---|
ACET | N/A | N/A | N/A | +60.02% |
ACET Peer | N/A | 13.1 | N/A | +82.03% |
Pharmaceuticals: Major Industry | 23.3 | 16.0 | 0.3 | +51.12% |
Health Technology Sector | 30.9 | 20.2 | 0.5 | +6.50% |
S&P 500 Market | 30.7 | 26.3 | 1.1 | +99.25% |
Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | |
---|---|---|---|---|
Mean Estimate | -$0.45 | -$0.47 | -$0.27 | -$0.46 |
Previous Mean | -$0.53 | -$0.47 | -$0.27 | N/A |
Standard Deviation | 0.06 | 0.07 | 0.78 | 0.17 |
Low Estimate | -$0.53 | -$0.57 | -$0.63 | -$0.63 |
High Estimate | -$0.37 | -$0.37 | $1.93 | -$0.30 |